Verifying…
Home / Drug A–Z / Lifeline Captopril 25 mg Tablets

Lifeline Captopril 25 mg Tablets

NAFDAC Reg. No. A4-6728 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Lifeline Captopril 25 mg Tablets
NAFDAC number
A4-6728
Active ingredient
Captopril
Strength
25 mg
Form
Tablet
Manufacturer
Not listed
Applicant (holder)
Life - Line Pharmaceuticals Ltd
Approved
21 Dec 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
20 Dec 2025
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Lifeline Captopril 25 mg Tablets is on the NAFDAC register with an active registration (A4-6728). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Lifeline Captopril 25 mg Tablets is used for

From the official U.S. FDA label for captopril, the active ingredient registered with NAFDAC.

Boxed warning: FETAL TOXICITY When pregnancy is detected, discontinue captopril tablets as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS: Fetal Toxicity
What it is used for

Hypertension Captopril tablets are indicated for the treatment of hypertension. In using captopril tablets, consideration should be given to the risk of neutropenia/agranulocytosis (see WARNINGS ). Captopril tablets may be used as initial therapy for patients with normal renal function, in whom the risk is relatively low. In patients with impaired renal function, particularly those with collagen vascular disease, captopril should be reserved for hypertensives who have either developed unacceptable side effects on other drugs, or have failed to respond satisfactorily to drug combinations. …

Possible side effects

Reported incidences are based on clinical trials involving approximately 7000 patients. Renal About one of 100 patients developed proteinuria (see WARNINGS ). Each of the following has been reported in approximately 1 to 2 of 1000 patients and are of uncertain relationship to drug use: renal insufficiency, renal failure, nephrotic syndrome, polyuria, oliguria, and urinary frequency. Hematologic Neutropenia/agranulocytosis has occurred (see WARNINGS ). Cases of anemia, thrombocytopenia, and pancytopenia have been reported. …

Do not use if

Captopril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin- converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor). Do not co-administer aliskiren with captopril tablets in patients with diabetes (see PRECAUTIONS : Drug Interactions ). Captopril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). …

Warnings

Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including captopril tablets) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema involving the extremities, face, lips, mucous membranes, tongue, glottis or larynx has been seen in patients treated with ACE inhibitors, including captopril. If angioedema involves the tongue, glottis or larynx, airway obstruction may occur and be fatal. …

Pregnancy & breastfeeding

Pregnancy Female patients of childbearing age should be told about the consequences of exposure to captopril tablets during pregnancy. Discuss treatment options with women planning to become pregnant. Patients should be asked to report pregnancies to their physicians as soon as possible.

Storage

STORAGE Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Lifeline Captopril 25 mg Tablets

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Lifeline Captopril 25 mg Tablets

What is in Lifeline Captopril 25 mg Tablets?

Lifeline Captopril 25 mg Tablets contains Captopril (25 mg), as tablet, according to its NAFDAC registration record.

Is Lifeline Captopril 25 mg Tablets registered with NAFDAC?

Yes. Lifeline Captopril 25 mg Tablets is listed on the NAFDAC register under registration number A4-6728, and its registration is active as of 5 November 2026.

Has Lifeline Captopril 25 mg Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Lifeline Captopril 25 mg Tablets in our automatically synced alert list.

How can I check that my pack of Lifeline Captopril 25 mg Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-6728, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Lifeline Captopril 25 mg Tablets used for?

Hypertension Captopril tablets are indicated for the treatment of hypertension. In using captopril tablets, consideration should be given to the risk of neutropenia/agranulocytosis (see WARNINGS ). Captopril tablets may be used as initial therapy for patients with normal renal function, in whom the risk is relatively low. In patients with impaired renal function, particularly those with collagen v (Summarised from the official U.S. FDA label for captopril. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Lifeline Captopril 25 mg Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.